These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7243129)

  • 1. Ovarian hyperthecosis: in vivo and in vitro correlations of the androgen profile.
    Belisle S; Lehoux JG; Benard B; Ainmelk Y
    Obstet Gynecol; 1981 Jun; 57(6 Suppl):70S-5S. PubMed ID: 7243129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Massive edema of the ovary and virilization.
    Vasquez SB; Sotos JF; Kim MH
    Obstet Gynecol; 1982 Jun; 59(6 Suppl):95S-9S. PubMed ID: 6283445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral and Ovarian Steroids in Ovarian Hyperthecosis.
    Abraham GE; Buster JE
    Obstet Gynecol; 1976 May; 47(5):581-6. PubMed ID: 1264403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of selective venous catheterization in localizing a small androgen-producing tumor in ovary.
    Nishiyama S; Hirota Y; Udagawa Y; Kato R; Hayakawa N; Tukada K
    Med Sci Monit; 2008 Feb; 14(2):CS9-12. PubMed ID: 18227769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian pathology associated with insulin resistance and acanthosis nigricans.
    Annos T; Taymor ML
    Obstet Gynecol; 1981 Nov; 58(5):662-4. PubMed ID: 7301247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian hyperandrogenism and androgen-producing tumors.
    Lobo RA
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):773-805. PubMed ID: 1778177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian hyperthecosis in the setting of portal hypertension.
    Speiser PW; Susin M; Sasano H; Bohrer S; Markowitz J
    J Clin Endocrinol Metab; 2000 Feb; 85(2):873-7. PubMed ID: 10690904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical, hormonal and histological features in ovarian stromal hyperthecosis].
    Abuladze MV; Sharabidze NG
    Georgian Med News; 2006 Oct; (139):50-3. PubMed ID: 17077467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging appearance of ovarian stromal hyperplasia and ovarian hyperthecosis.
    Rosenkrantz AB; Popiolek D; Bennett GL; Hecht EM
    J Comput Assist Tomogr; 2009; 33(6):912-6. PubMed ID: 19940659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective ovarian vein sampling to localize a Leydig cell tumor.
    Dickerson RD; Putman MJ; Black ME; Pinto KR; Diamond NG; Marynick S; Pinto AB
    Fertil Steril; 2005 Jul; 84(1):218. PubMed ID: 16009186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy after unilateral oophorectomy in a woman with hyperthecosis ovarii. A case report.
    Rezai P; Lui P
    J Reprod Med; 1994 Sep; 39(9):729-32. PubMed ID: 7807488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
    Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
    Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral ovarian stromal hyperplasia concealing a nonhilar, pure stromal-Leydig cell tumor. A case report.
    Oler A; Singh M; Ural SH
    J Reprod Med; 1999 Jun; 44(6):563-6. PubMed ID: 10394554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric hyperthecosis ovarii.
    Farber M; Madanes A; O'Briain DS; Millan VG; Turksoy RN; Rule AH
    Obstet Gynecol; 1981 Apr; 57(4):521-5. PubMed ID: 7243108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer.
    Jongen VH; Hollema H; van der Zee AG; Santema JG; Heineman MJ
    BJOG; 2003 Jul; 110(7):690-5. PubMed ID: 12842061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective ovarian vein sampling can be crucial to localize a Leydig cell tumor: an unusual case in a postmenopausal woman.
    Ozgun MT; Batukan C; Turkyilmaz C; Dolanbay M; Mavili E
    Maturitas; 2008 Nov; 61(3):278-80. PubMed ID: 18930614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Androgenic alopecia revealing an androgen secreting ovarian tumor].
    Roux-Guinot S; Gorin I; Vadrot D; Djid R; Bethoux JP; Escande JP
    Ann Dermatol Venereol; 2001 Nov; 128(11):1241-4. PubMed ID: 11908171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE; Anania C; Malinak R
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a gonadotropin-releasing hormone agonist in the evaluation of postmenopausal virilization due to ovarian hyperthecosis. A case report.
    Koroscil TM; Harter SB; Ouweleen J; Blauer KL
    J Reprod Med; 1996 Apr; 41(4):259-62. PubMed ID: 8728079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthecosis of the ovaries in acromegaly.
    Nagamani M; Lingold JC; Gomez LG
    Obstet Gynecol; 1980 Aug; 56(2):258-62. PubMed ID: 7393521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.